Trial intelligence / Profile preview

Analysis of the Acceptance and Perceived Effectiveness of a Product for Maintaining Intimate pH

RBR-9fcpncqPhase 2Not yet recruiting

Sponsor
Medcin Instituto da Pele
Start
Jan 2025
Countries
1
01

Overview

Phase 2, open-label, single-arm trial, sponsored by Medcin Instituto da Pele. Primary endpoints: User acceptance and Perceived effectiveness. Planned start Jan 2025; status: not yet recruiting.

Beyond the preview

Go deeper on RBR-9fcpncq.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on RBR-9fcpncq.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call